153 related articles for article (PubMed ID: 38285771)
21. The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer.
Huang CW; Sun LC; Shih YL; Tsai HL; Chen CW; Yeh YS; Ma CJ; Huang CJ; Wang JY
World J Surg Oncol; 2012 May; 10():76. PubMed ID: 22553992
[TBL] [Abstract][Full Text] [Related]
22. Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002-2011.
El Brahimi S; Smith ML; Pinheiro PS
Int J Colorectal Dis; 2019 Aug; 34(8):1467-1475. PubMed ID: 31289849
[TBL] [Abstract][Full Text] [Related]
23. Colorectal Cancer Risks According to Sex Differences in Patients With Type II Diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study.
Lee JM; Lee KM; Kim DB; Ko SH; Park YG
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00090. PubMed ID: 31651449
[TBL] [Abstract][Full Text] [Related]
24. Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk.
de Kort S; Simons CCJM; van den Brandt PA; Janssen-Heijnen MLG; Sanduleanu S; Masclee AAM; Weijenberg MP
Int J Cancer; 2019 Oct; 145(7):1774-1781. PubMed ID: 31018241
[TBL] [Abstract][Full Text] [Related]
25. Marked paper: Type 2 diabetes mellitus indicates increased postoperative complications and poor prognosis in colorectal cancer patients receiving curative surgery.
Liu D; Zhang X; Zhou H; Zhu Z; He Y; Wan X; Zhang B; Liu S; Liu L
Front Oncol; 2023; 13():1128383. PubMed ID: 36845740
[TBL] [Abstract][Full Text] [Related]
26. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
[TBL] [Abstract][Full Text] [Related]
27. The prognostic role of fasting plasma glucose levels on survival in advanced colorectal cancer patients with type II diabetes mellitus: a retrospective cohort study.
Meng Q; Yu Y; Wang K; Zhang Z; Zhao J; Wang Y; Hao D; Wang G
J Gastrointest Oncol; 2022 Dec; 13(6):3080-3089. PubMed ID: 36636046
[TBL] [Abstract][Full Text] [Related]
28. [Effect of metformin on colorectal carcinoma in type 2 diabetes mellitus patients: a Markov model analysis].
Su T; Liao B; Dong Y; Peng Z; Zhou Q; Li B; Peng S; Zhang N
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):689-693. PubMed ID: 28643317
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Type 2 Diabetes Mellitus on the Short-Term Outcomes and Prognosis of Stage I-III Colorectal Cancer: A Propensity Score Matching Analysis.
Cheng Y; Cheng YX; Liu XY; Kang B; Tao W; Peng D
Cancer Manag Res; 2022; 14():205-214. PubMed ID: 35046727
[TBL] [Abstract][Full Text] [Related]
30. Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.
Shami JJP; Yan VKC; Wei Y; Alwafi H; Blais JE; Wan E; Wong CKH; Cheung KS; Leung WK; Wong MCS; Wong ICK; Chan EW
J Intern Med; 2023 Mar; 293(3):371-383. PubMed ID: 36382924
[TBL] [Abstract][Full Text] [Related]
31. Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.
Ramanathan RK; Rothenberg ML; de Gramont A; Tournigand C; Goldberg RM; Gupta S; André T
Ann Oncol; 2010 Apr; 21(4):754-758. PubMed ID: 19887466
[TBL] [Abstract][Full Text] [Related]
32. Diabetes-specific Modulation of Peripheral Blood Gene Expression Signatures in Colorectal Cancer.
Molnár Z; Bánlaki Z; Somogyi A; Herold Z; Herold M; Guttman A; Rónai Z; Keszler G
Curr Mol Med; 2020; 20(10):773-780. PubMed ID: 32364075
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
Deng Y; Wang J; Li W; Xiong W; Wang X
J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
[TBL] [Abstract][Full Text] [Related]
34. Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic review.
Guraya SY
World J Gastroenterol; 2015 May; 21(19):6026-31. PubMed ID: 26019469
[TBL] [Abstract][Full Text] [Related]
35. High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist.
Ma B; Wang X; Ren H; Li Y; Zhang H; Yang M; Li J
BMC Cancer; 2023 Jun; 23(1):594. PubMed ID: 37370018
[TBL] [Abstract][Full Text] [Related]
36. Expression of long non-coding RNA
Zhao M; Wang H; Chen J; Xi Y; Wang F; Huo C; Li W; Chu Y; Xu P; Huang Q; Bu S
Arch Physiol Biochem; 2021 Jun; 127(3):228-234. PubMed ID: 31232113
[TBL] [Abstract][Full Text] [Related]
37. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
Wang Y; Xiao J; Zhao Y; Du S; Du J
Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
[TBL] [Abstract][Full Text] [Related]
38. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
[TBL] [Abstract][Full Text] [Related]
39. Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies.
Yu F; Guo Y; Wang H; Feng J; Jin Z; Chen Q; Liu Y; He J
BMC Cancer; 2016 Aug; 16():642. PubMed ID: 27535548
[TBL] [Abstract][Full Text] [Related]
40. The Use of Metformin and Postoperative Insulin Pump Were Predictive Factors for Outcomes of Diabetic Colorectal Cancer Patients after Surgery.
Liu XR; Liu F; Li ZW; Lv Q; Shu XP; Li LS; Tong Y; Zhang W; Peng D
Nutr Cancer; 2023; 75(10):1926-1933. PubMed ID: 37870939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
